Holmes Tremors in a 60-year-old Woman Following Primary Brainstem hemorrhage (PBH) Responsive to Standard Dose of Trihexyphenidyl: A case report and literature review
Abstract
Introduction: The Holmes tremor, once known as rubral or mesencephalic tremor, is an uncommon and atypical condition that presents as an irregular resting tremor, often accompanied by an action tremor that worsens with certain postures. This phenomenon is primarily caused by vascular or traumatic injuries that impact the cerebellothalamocortical pathway and the Guillain-Mollaret triangle. Currently, there is no therapeutic protocol based on randomized clinical trials, and the efficacy of the proposed treatments varies significantly. First-line pharmacological treatments include levodopa, levetiracetam, and trihexyphenidyl, the latter frequently prescribed at high doses. We present a case of Holmes tremor associated with a pontine-mesencephalic hematoma, which showed a favorable response to standard-dose trihexyphenidyl.
Clinical case: A 60-year-old patient presented with a hemorrhagic stroke in the brainstem secondary to hypertensive microangiopathy, characterized by a sudden disturbance in consciousness and a favorable outcome. After twenty-six days, Holmes tremors were observed in the right brachiofacial area. The patient was started on trihexyphenidyl at standard doses, which were gradually increased to a total of 12 mg taken in three doses, resulting in nearly complete resolution of the tremors. At the three-month follow-up, the patient exhibited only mild dysarthria as a residual effect.
Conclusion: The choice to administer trihexyphenidyl was particularly challenging…
How strong is the evidence?
Evidence Hub reads this as a case report, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health.
Read the paper
Related studies
- Antioxidant efficacy and the upregulation of Nrf2-mediated HO-1 expression by (+)-lariciresinol, a lignan isolated from Rubia philippinensis, through the activation of p38
- Anti-influenza virus activity of green tea by-products in vitro and efficacy against influenza virus infection in chickens
- Therapeutic Potential of Mesenchymal Stem Cells (MSCs) and MSC-Derived Extracellular Vesicles for the Treatment of Spinal Cord Injury
- The intratumoral administration of ferucarbotran conjugated with doxorubicin improved therapeutic effect by magnetic hyperthermia combined with pharmacotherapy in a hepatocellular carcinoma model
- Enhanced anticancer efficacy of TRAIL-conjugated and odanacatib-loaded PLGA nanoparticles in TRAIL resistant cancer
- In vivo tracking of bioorthogonally labeled T-cells for predicting therapeutic efficacy of adoptive T-cell therapy
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.